Is HeartFlow (HTFL) Already Overvalued Or Still Worth The Hype?

HeartFlow (HTFL) has returned 69.1% over the past month and 35.0% over the last year, raising the question of whether optimism has already been reflected in the share price. Simply Wall St’s valuation screen gives the company 0 of 6 checks, suggesting it is expensive rather than a clear bargain. Because HeartFlow continues to report free cash flow losses, price-to-sales is a relevant valuation measure. The stock trades at 17.3x sales, compared with a Healthcare Services industry average of 2.9x and a peer-group average of 4.3x. Simply Wall St estimates a fair multiple of 7.4x, based on HeartFlow’s sector, size and risk profile. Despite raised 2026 revenue guidance in its recent results, the current multiple remains well above that tailored benchmark and broader industry measures. The valuation case depends on continued adoption of HeartFlow’s AI platform for diagnosing coronary artery disease, along with uptake of newer products such as Plaque Analysis. Slower adoption, weaker-than-expected product expansion or reduced confidence in the growth outlook could make investors less willing to pay the current premium. Sustained revenue traction, however, could help support the valuation. Simply Wall St Narratives connect HeartFlow’s valuation with explicit assumptions about future growth, margins and earnings. Each narrative links a fair-value estimate to potential catalysts and risks, helping investors assess which scenario is developing as new results emerge. The central question is whether the raised 2026 revenue guidance, AI platform and Plaque Analysis can justify today’s price. HeartFlow therefore screens as overvalued on market multiples, although that does not rule out further upside. The bull and bear cases depend on the durability of confidence in its business model and growth outlook. This Simply Wall St commentary is general in nature and uses historical data and analyst forecasts. It is not financial advice or a recommendation to buy or sell HTFL, does not consider individual objectives or financial circumstances, and may not reflect the latest price-sensitive announcements or qualitative information. Simply Wall St has no position in the stock.